Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05808699 · ClinicalTrials.gov registry record
Camera Qualification Study
A clinical trial of Diabetic Retinopathy, sponsored by Digital Diagnostics.
- Active
- Registry status
- 626
- Enrollment target
- 9
- Study locations
NCT05808699: Active study of Diabetic Retinopathy, sponsored by Digital Diagnostics.
NCT05808699 is a study of Diabetic Retinopathy that is active but no longer recruiting, run by Digital Diagnostics. The registered enrollment target is 626 participants, below the 1,665-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (62% lower). The trial reports 9 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05808699, a study of Diabetic Retinopathy, is active but no longer recruiting, sponsored by Digital Diagnostics.
- ACTIVE NOT RECRUITING
- Registry status
- 626 participants
- Enrollment target
- 9
- Study locations
Study Summary
A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.
Primary Outcome
Estimation sensitivity and specificity corrected for enrichment using logistic regression, Level 1
Conditions Studied
Interventions
- DEVICE handheld fundus camera
Study Locations (9)
California
- Infinity Clinical Research - Norco
- Dream Team - Pomona
Florida
- East Cost Institute for Research - Jacksonville
- Ocean Wellness Center - Miami Gardens
Texas
- Allure Health - Friendswood
- Mt. Olympus Medical Research - Sugar Land
Mississippi
- Olive Branch Family Medical Center - Olive Branch
Montana
- Logan Health - Kalispell
North Dakota
- Lillestol Research, LLC - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 626 participants |
| Start Date | 2023-03-03 |
| Est. Completion | 2025-01-30 |
What the registry record for NCT05808699 still lists
NCT05808699 is an observational study that tracks outcomes without assigning an intervention. The registered 626 participants enrollment target is mid-sized for trials with a published cap, below the 1,665-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 1 intervention - of which handheld fundus camera is the first listed.
NCT05808699 lists 9 locations in 6 states (California, Florida, Texas).
Frequently Asked Questions
What is clinical trial NCT05808699 about?
NCT05808699 is a clinical study titled "Camera Qualification Study". A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.
What is the current status of trial NCT05808699?
This trial is currently active not recruiting. The enrollment target is 626 participants. The study started on 2023-03-03. Estimated completion is 2025-01-30.
What conditions does trial NCT05808699 study?
This clinical trial studies the following conditions: Diabetic Retinopathy.
What interventions are being tested in trial NCT05808699?
The interventions under investigation include: handheld fundus camera (DEVICE).
Who is sponsoring clinical trial NCT05808699?
This trial is sponsored by Digital Diagnostics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05808699 being conducted?
This trial has 9 study locations across California, Florida, Mississippi, Montana, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05808699's enrollment target sits among peer trials
626 13th of 57 higher than 45 of 57 other Diabetic Retinopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Retinopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fenofibrate for Prevention of DR Worsening
RECRUITING · Phase 3
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
RECRUITING
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06040827 · 626 participants
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI